| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Butera Salvatore Thomas | CEO, Volition Veterinary | 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON | /s/ Salvatore Thomas Butera | 03 Jun 2025 | 0001834339 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VNRX | Common Stock | Award | $0 | +23,377 | +7.7% | $0.000000 | 326,062 | 01 Jun 2025 | Direct | F1 |
| transaction | VNRX | Common Stock | Tax liability | $5,877 | -11,683 | -3.6% | $0.5030 | 314,379 | 01 Jun 2025 | Direct | F2 |
| holding | VNRX | Common Stock | 99,350 | 01 Jun 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On June 1, 2025, the reporting person was awarded 23,377 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan in lieu of cash compensation that would otherwise have been owed to the reporting person. The RSUs partially vest in three installments of 7,793 units, 7,792 units, and 7,792 units on each of June 1, 2025, July 1, 2025 and August 1, 2025, respectively, are also subject to further time-based vesting in a single installment on August 1, 2025, and are generally subject to continued service throughout each applicable vesting date. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |
| F2 | Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation to satisfy the tax withholding obligations of the reporting person upon settlement of 35,783 restricted stock units that were awarded in lieu of cash compensation that would otherwise have been owed to the reporting person. No shares were sold by the reporting person or VolitionRx in such transaction. |
| F3 | These shares of common stock are jointly owned by the reporting person and his spouse. |